Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

The CRB1 Complex: Following the Trail of Crumbs to a Feasible Gene Therapy Strategy.

Quinn PM, Pellissier LP, Wijnholds J.

Front Neurosci. 2017 Apr 5;11:175. doi: 10.3389/fnins.2017.00175. eCollection 2017. Review.

2.

Generation of induced pluripotent stem cells with high efficiency from human embryonic renal cortical cells.

Yao L, Chen R, Wang P, Zhang Q, Tang H, Sun H.

Am J Transl Res. 2016 Nov 15;8(11):4982-4993. eCollection 2016.

3.

Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines.

Fujimori K, Tezuka T, Ishiura H, Mitsui J, Doi K, Yoshimura J, Tada H, Matsumoto T, Isoda M, Hashimoto R, Hattori N, Takahashi T, Morishita S, Tsuji S, Akamatsu W, Okano H.

Mol Brain. 2016 Oct 3;9(1):88.

4.

Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases.

Shi L, Cui Y, Luan J, Zhou X, Han J.

Intractable Rare Dis Res. 2016 Aug;5(3):192-201. doi: 10.5582/irdr.2016.01062. Review.

5.

The Generation of Human Induced Pluripotent Stem Cells from Blood Cells: An Efficient Protocol Using Serial Plating of Reprogrammed Cells by Centrifugation.

Kim Y, Rim YA, Yi H, Park N, Park SH, Ju JH.

Stem Cells Int. 2016;2016:1329459. doi: 10.1155/2016/1329459. Epub 2016 Aug 4.

6.

Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory.

Saito H, Okita K, Chang AE, Ito F.

Cancer Res. 2016 Jun 15;76(12):3473-83. doi: 10.1158/0008-5472.CAN-15-1742. Epub 2016 Apr 12.

7.

Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.

Wen W, Zhang JP, Xu J, Su RJ, Neises A, Ji GZ, Yuan W, Cheng T, Zhang XB.

Stem Cell Reports. 2016 Jun 14;6(6):873-84. doi: 10.1016/j.stemcr.2016.04.005. Epub 2016 May 5.

8.

Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases.

Sugimoto C, Fujita H, Wakao H.

World J Stem Cells. 2016 Apr 26;8(4):158-69. doi: 10.4252/wjsc.v8.i4.158. Review.

9.

Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease.

Yu H, Cowan CA.

Mol Endocrinol. 2016 Jun;30(6):575-86. doi: 10.1210/me.2015-1290. Epub 2016 Apr 13.

10.

Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells.

Saito H, Okita K, Fusaki N, Sabel MS, Chang AE, Ito F.

Stem Cells Int. 2016;2016:8394960. doi: 10.1155/2016/8394960. Epub 2015 Dec 28.

11.

Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy.

Rami F, Mollainezhad H, Salehi M.

Genet Res Int. 2016;2016:3451807. doi: 10.1155/2016/3451807. Epub 2016 Feb 25. Review.

12.

Functional Neurons Generated from T Cell-Derived Induced Pluripotent Stem Cells for Neurological Disease Modeling.

Matsumoto T, Fujimori K, Andoh-Noda T, Ando T, Kuzumaki N, Toyoshima M, Tada H, Imaizumi K, Ishikawa M, Yamaguchi R, Isoda M, Zhou Z, Sato S, Kobayashi T, Ohtaka M, Nishimura K, Kurosawa H, Yoshikawa T, Takahashi T, Nakanishi M, Ohyama M, Hattori N, Akamatsu W, Okano H.

Stem Cell Reports. 2016 Mar 8;6(3):422-35. doi: 10.1016/j.stemcr.2016.01.010. Epub 2016 Feb 18.

13.

Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds.

Ye J, Ge J, Zhang X, Cheng L, Zhang Z, He S, Wang Y, Lin H, Yang W, Liu J, Zhao Y, Deng H.

Cell Res. 2016 Jan;26(1):34-45. doi: 10.1038/cr.2015.142. Epub 2015 Dec 25.

14.

Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications.

Cefalo MG, Carai A, Miele E, Po A, Ferretti E, Mastronuzzi A, Germano IM.

Stem Cells Int. 2016;2016:4869071. doi: 10.1155/2016/4869071. Epub 2015 Nov 30. Review.

15.

Generation of Induced Pluripotent Stem Cells from Human Peripheral T Cells Using Sendai Virus in Feeder-free Conditions.

Kishino Y, Seki T, Yuasa S, Fujita J, Fukuda K.

J Vis Exp. 2015 Nov 11;(105). doi: 10.3791/53225.

16.

Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges.

Seah YF, El Farran CA, Warrier T, Xu J, Loh YH.

Int J Mol Sci. 2015 Dec 2;16(12):28614-34. doi: 10.3390/ijms161226119. Review.

17.

Urine-derived induced pluripotent stem cells as a modeling tool for paroxysmal kinesigenic dyskinesia.

Zhang SZ, Li HF, Ma LX, Qian WJ, Wang ZF, Wu ZY.

Biol Open. 2015 Nov 30;4(12):1744-52. doi: 10.1242/bio.013078.

18.

Successful Generation of Human Induced Pluripotent Stem Cell Lines from Blood Samples Held at Room Temperature for up to 48 hr.

Agu CA, Soares FA, Alderton A, Patel M, Ansari R, Patel S, Forrest S, Yang F, Lineham J, Vallier L, Kirton CM.

Stem Cell Reports. 2015 Oct 13;5(4):660-71. doi: 10.1016/j.stemcr.2015.08.012. Epub 2015 Sep 17.

19.

HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.

Hinson JT, Chopra A, Nafissi N, Polacheck WJ, Benson CC, Swist S, Gorham J, Yang L, Schafer S, Sheng CC, Haghighi A, Homsy J, Hubner N, Church G, Cook SA, Linke WA, Chen CS, Seidman JG, Seidman CE.

Science. 2015 Aug 28;349(6251):982-6. doi: 10.1126/science.aaa5458.

20.

Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.

Tanaka A, Yuasa S, Node K, Fukuda K.

Int J Mol Sci. 2015 Aug 12;16(8):18894-922. doi: 10.3390/ijms160818894. Review.

Supplemental Content

Support Center